Precision Therapeutics (NASDAQ:AIPT) posted its earnings results on Wednesday. The medical instruments supplier reported ($0.21) earnings per share for the quarter, Morningstar.com reports. The business had revenue of $0.26 million during the quarter. Precision Therapeutics had a negative return on equity of 346.59% and a negative net margin of 713.80%.
Shares of AIPT remained flat at $$0.63 during trading hours on Thursday. 12,201 shares of the stock traded hands, compared to its average volume of 81,873. Precision Therapeutics has a 52-week low of $0.60 and a 52-week high of $1.58.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Stock Observer and is the property of of Stock Observer. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://www.thestockobserver.com/2019/05/16/precision-therapeutics-aipt-releases-quarterly-earnings-results-2.html.
About Precision Therapeutics
Precision Therapeutics Inc provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables.
Featured Story: How accurate is the Rule of 72?
Receive News & Ratings for Precision Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.